Abstract
Development of RGD-modified nanoparticles with epigallocatechin gallate (EGCG) loading as ophthalmic nanomedicine to inhibit corneal neovascularization development
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
